| Filed On | Filing |
|---|---|
| 22 Dec 2023 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This agreement contains the terms of your position as Interim Principal Executive Officer of Eagle Pharmaceuticals, Inc. (the “Company”) and Interim Executive Chairman (the “Interim Executive Chair”) of the Board of Directors of the Comp... |
| 10 Jan 2023 |
8-K/A: Regulation FD Disclosure
© 2023 Eagle Pharmaceuticals, Inc. All rights reserved. 1 © 2023 Eagle Pharmaceuticals, Inc. All rights reserved. Company Overview J.P. Morgan Healthcare Conference January 2023 |
| 09 Nov 2022 |
8-K/A: Results of Operations and Financial Condition
Eagle Pharmaceuticals, Inc. is re-issuing in its entirety its earnings press release for the third quarter ended September 30, 2022, originally issued on November 7, 2022 at 6:50 am ET, to correct errors in the presentation of certain li... |
| 25 Aug 2022 |
8-K/A: Financial Statements and Exhibits
To the Management and the Board of Directors of Acacia Pharma Group Limited |
| 04 Aug 2022 |
8-K/A: Submission of Matters to a Vote of Security Holders
As reported in the Original 8-K, at the Company’s Annual Meeting of Shareholders held on July 28, 2022, a majority of the Company’s shareholders that voted on the matter indicated a preference to hold, on a non-binding advisory basis, th... |
| 08 Nov 2021 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 28 Dec 2020 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 11 Oct 2019 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 01 Feb 2017 | 8-K/A: Financial Statements and Exhibits |
| 21 Apr 2016 | 8-K/A: Regulation FD Disclosure |
| 21 Sep 2015 | 8-K/A: Regulation FD Disclosure |
Loading...
